Wikisage, the free encyclopedia of the second generation, is digital heritage
Eslicarbazepine: Difference between revisions
Jump to navigation
Jump to search
(Created page with "is an AED. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy o...") |
mNo edit summary |
||
Line 1: | Line 1: | ||
is an [[antiepileptic drug|AED]]. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases</ref> | is an [[antiepileptic drug|AED]]. Adjunctive eslicarbazepine led to seizure reduction in two patients with severe myoclonic epilepsy of infancy<ref>Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two cases</ref> | ||
==Pharmacy and chemistry== | |||
Eslicarbamazepine acetate is an once-daily antiepileptic that was approved in 2009 by the [[European Medicines Agency|EMA]] (Zerebix TM)<ref>[A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures]</ref> | |||
<references/> | <references/> |